Delayed Graft Function Risk Not Lowered with High-Dose EPO - Renal and Urology News PDF Print
Renal and Urology News
The double-blind, placebo-controlled study, by a team at Leiden University Medical Center in Leiden, The Netherlands, included 92 renal transplant recipients who received organs from non-heart-beating donors. Those assigned to the EPO group received

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.